FR7472M - - Google Patents

Info

Publication number
FR7472M
FR7472M FR147685A FR147685A FR7472M FR 7472 M FR7472 M FR 7472M FR 147685 A FR147685 A FR 147685A FR 147685 A FR147685 A FR 147685A FR 7472 M FR7472 M FR 7472M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR147685A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR7472M publication Critical patent/FR7472M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR147685A 1967-04-10 1968-04-10 Expired FR7472M (en:Method)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62938267A 1967-04-10 1967-04-10
US62938367A 1967-04-10 1967-04-10

Publications (1)

Publication Number Publication Date
FR7472M true FR7472M (en:Method) 1969-12-01

Family

ID=27090926

Family Applications (1)

Application Number Title Priority Date Filing Date
FR147685A Expired FR7472M (en:Method) 1967-04-10 1968-04-10

Country Status (19)

Country Link
US (2) US3511872A (en:Method)
JP (1) JPS4940705B1 (en:Method)
AT (1) AT284842B (en:Method)
BE (1) BE713499A (en:Method)
CH (1) CH534130A (en:Method)
CY (1) CY721A (en:Method)
DE (1) DE1770163A1 (en:Method)
DK (1) DK127725B (en:Method)
ES (1) ES352582A1 (en:Method)
FR (1) FR7472M (en:Method)
GB (1) GB1220468A (en:Method)
IE (1) IE32334B1 (en:Method)
IL (1) IL29775A (en:Method)
MY (1) MY7400056A (en:Method)
NL (1) NL6805079A (en:Method)
NO (1) NO132093C (en:Method)
OA (1) OA03854A (en:Method)
PL (1) PL79312B1 (en:Method)
SE (1) SE364273B (en:Method)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2411825A1 (fr) * 1977-02-26 1979-07-13 Hokuriku Pharmaceutical N-(trifluoromethyl-3-phenyl) anthranilate d'alcoyle, utilise comme agent anti-inflammatoire
FR2546885A1 (fr) * 1983-06-06 1984-12-07 Fabre Sa Pierre Oxamates d'anthranilates fonctionnalises utiles comme medicaments dans le traitement des dermatoses inflammatoires

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852333A (en) * 1967-10-23 1974-12-03 Parke Davis & Co New anthranilic acid{60 -monoglycerides
DE1939111C3 (de) * 1969-08-01 1974-04-18 Troponwerke Dinklage & Co, 5000 Koeln Derivate der N- eckige Klammer auf 3-Trifluormethylphenyl eckige Klammer zu -anthranilsäure, Verfahren zu ihrer Herstellung und pharmakologisch wirksame Zubereitungen derselben
FR2154330A1 (en) * 1971-09-30 1973-05-11 Crt 2'-(3'-trifluoromethylthio-aniline)-glycerol nicotinate - anti -anflammatory and antipyretic
DE2806597A1 (de) * 1978-02-16 1979-08-30 Bosch Gmbh Robert Schaltungsanordnung zur verbesserung der selbsterregung von generatoren
US4168313A (en) * 1978-02-21 1979-09-18 Sebastian Bago Phthalidyl 2-(3'-trifluoromethyl-anilino)-pyridine-3-carboxylate and its salts
JPS5545615A (en) * 1978-09-27 1980-03-31 Nissan Chem Ind Ltd Derivative of (n-allyl-o-(2,6-dichloroanilino) phenyl) acetic acid
US4255581A (en) * 1979-08-13 1981-03-10 Laboratories Bago, S.A. Process for the preparation of alkyl and aryl esters of 3'-substituted and 2', 3'-disubstituted 2-anilino-3-pyridinecarboxylic acids
DK8502611A (en:Method) * 1985-08-08 1986-12-12
EP4021449A4 (en) * 2019-08-30 2023-11-01 University of South Florida STITCH MODULATORS, COMPOSITIONS AND METHODS OF USE
CN118234498A (zh) * 2021-09-03 2024-06-21 南佛罗里达大学 Sting调节剂、组合物及其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2408905A (en) * 1941-11-29 1946-10-08 Ind Patents Corp Preparation of synthetic glycerides
US3390172A (en) * 1964-03-27 1968-06-25 Parke Davis & Co Nu-(3-trifluoromethylphenyl)-anthranilic acids

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2411825A1 (fr) * 1977-02-26 1979-07-13 Hokuriku Pharmaceutical N-(trifluoromethyl-3-phenyl) anthranilate d'alcoyle, utilise comme agent anti-inflammatoire
FR2546885A1 (fr) * 1983-06-06 1984-12-07 Fabre Sa Pierre Oxamates d'anthranilates fonctionnalises utiles comme medicaments dans le traitement des dermatoses inflammatoires

Also Published As

Publication number Publication date
DK127725B (da) 1973-12-24
SE364273B (en:Method) 1974-02-18
ES352582A1 (es) 1969-07-01
PL79312B1 (en) 1975-06-30
US3478040A (en) 1969-11-11
NO132093C (en:Method) 1975-09-17
NL6805079A (en:Method) 1968-10-11
AT284842B (de) 1970-09-25
GB1220468A (en) 1971-01-27
CY721A (en) 1974-02-13
US3511872A (en) 1970-05-12
DE1770163A1 (de) 1972-03-09
OA03854A (fr) 1971-12-24
IE32334L (en) 1968-10-10
NO132093B (en:Method) 1975-06-09
IL29775A (en) 1972-04-27
BE713499A (en:Method) 1968-10-10
MY7400056A (en) 1974-12-31
JPS4940705B1 (en:Method) 1974-11-05
IE32334B1 (en) 1973-06-27
CH534130A (de) 1973-02-28

Similar Documents

Publication Publication Date Title
JPS4940705B1 (en:Method)
BE702798A (en:Method)
BE708968A (en:Method)
BE709822A (en:Method)
BE709117A (en:Method)
BE706532A (en:Method)
BE698676A (en:Method)
BE710247A (en:Method)
BE697579A (en:Method)
BE709130A (en:Method)
BE700504A (en:Method)
BE706472A (en:Method)
BE707319A (en:Method)
BE708726A (en:Method)
BE707852A (en:Method)
BE699503A (en:Method)
BE709191A (en:Method)
BE711700A (en:Method)
BE709399A (en:Method)
BE706372A (en:Method)
BE709408A (en:Method)
BE708711A (en:Method)
BE712601A (en:Method)
BE708989A (en:Method)
BE695125A (en:Method)

Legal Events

Date Code Title Description
ST Notification of lapse